Acorda Therapeutics Inc (ACORQ)
0.85
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Acorda Therapeutics Net Income (TTM): -252.85M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -252.85M |
| September 30, 2023 | -15.95M |
| June 30, 2023 | -20.92M |
| March 31, 2023 | -58.22M |
| December 31, 2022 | -65.92M |
| September 30, 2022 | -105.62M |
| June 30, 2022 | -118.84M |
| March 31, 2022 | -95.02M |
| December 31, 2021 | -103.95M |
| September 30, 2021 | -166.43M |
| June 30, 2021 | -132.02M |
| March 31, 2021 | -126.57M |
| December 31, 2020 | -99.59M |
| September 30, 2020 | 49.11M |
| June 30, 2020 | -221.77M |
| March 31, 2020 | -231.83M |
| December 31, 2019 | -272.97M |
| September 30, 2019 | -329.03M |
| June 30, 2019 | -79.41M |
| March 31, 2019 | -5.724M |
| December 31, 2018 | 33.68M |
| September 30, 2018 | -145.99M |
| June 30, 2018 | -157.28M |
| March 31, 2018 | -211.67M |
| December 31, 2017 | -222.37M |
| Date | Value |
|---|---|
| September 30, 2017 | -55.39M |
| June 30, 2017 | -42.92M |
| March 31, 2017 | -53.00M |
| December 31, 2016 | -34.62M |
| September 30, 2016 | -22.32M |
| June 30, 2016 | -5.653M |
| March 31, 2016 | 13.62M |
| December 31, 2015 | 11.06M |
| September 30, 2015 | 2.183M |
| June 30, 2015 | 10.20M |
| March 31, 2015 | 13.88M |
| December 31, 2014 | 17.67M |
| September 30, 2014 | 23.53M |
| June 30, 2014 | 19.06M |
| March 31, 2014 | 18.28M |
| December 31, 2013 | 16.44M |
| September 30, 2013 | 143.22M |
| June 30, 2013 | 145.34M |
| March 31, 2013 | 145.97M |
| December 31, 2012 | 154.96M |
| September 30, 2012 | 34.68M |
| June 30, 2012 | 43.95M |
| March 31, 2012 | 39.12M |
| December 31, 2011 | 30.60M |
| September 30, 2011 | 21.58M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-329.03M
Minimum
Sep 2019
49.11M
Maximum
Sep 2020
-128.83M
Average
-105.62M
Median
Sep 2022
Net Income (TTM) Benchmarks
| BioSig Technologies Inc | -29.04M |
| Verve Therapeutics Inc | -200.07M |
| Spectral AI Inc | -19.05M |
| AIM ImmunoTech Inc | -28.96M |
| Protalix BioTherapeutics Inc | 8.312M |